DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients
DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients
Appetite loss is a severe and common symptom among late-stage cancer patients, and it causes
 great the anxiety for the patient's family. In TCM theory, the investigators call these
 patients are in block and repulsion condition. The investigators try to set a study to use
 the herbal medicine solution taken in frequent small amounts by cancer patients in late-stage
 to improve the appetite loss condition. Through this method, the investigators not only want
 to improve the quality of life of cancer patients in late-stage but also set a valuable
 treatment.
Intervention group

 -  1. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed
 and separated into four packages;

 -  2. each package was given to each patient four times a day (three time after meal and
 one time before sleep);

 -  3. each patient received the usual medication of the hospice ward at the same time;

 -  4. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st
 day, the 3rd day and the 6th day;

 -  5. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
 Oncology Group Performance Status) at the 1st day and the 6th day.

 Control group

 -  1. each patient received the usual medication of the hospice ward during the trial
 interval;

 -  2. record the patients' score of receive pre-test, mid-test and after-test of QIPCTP at
 the 1st day, the 3rd day and the 6th day;

 -  3. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative
 Oncology Group Performance Status) at at the 1st day and the 6th day.

 Medicine DaHuang herbal abstract powder is produced by Sun Ten Pharmaceutical Co., Ltd, and
 it's product serial number: 276001. GanCao herbal abstract powder is also produced by Sun Ten
 Pharmaceutical Co., Ltd, and it's product serial number: 185645. Each herbal abstract powder
 is qualified with the data of HPLC to confirm each content and stability. The pharmaceutical
 company is qualified by Good Manufacturing Practice (GMP) certification in Taiwan.
Inclusion Criteria:

 -  Terminal cancer patients in hospice ward

 -  Patients with appetite loss condition

 -  Ages between 20 to 80 years old

 -  No history of diabetes

 Exclusion Criteria:

 -  Entered the stage of dying patients

 -  Receiving other traditional Chinese medicine